Research Paper Volume 15, Issue 20 pp 11067—11091
HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma
Figure 13. The association between the HLA-DPA1 overexpression and immune cell markers in LUAD using the GEPIA database. (A) CD3D; (B) CD3E; (C) CD2; (D) HLA-DPB1; (E) HLA-DQB1; (F) HLA-DRA; (G) PDCD1; (H) CTLA4; (I) LAG3. Abbreviation: LUAD: lung adenocarcinoma.